National health insurance covers record 724,000 patients in Moldova during 2025
The National Health Insurance Company (CNAM) allocated over 1.2 billion MDL (approx. €61.2 million) in 2025 to support the continuous treatment of patients through subsidized medicines and medical devices.
These resources reached more than 724,000 individuals, effectively benefiting nearly one out of every three citizens in the Republic of Moldova.
Expansion of subsidized drug lists
During the past year, the list of compensated medicines grew to include seven new International Nonproprietary Names (INN). These additions focus on treating cardiovascular diseases, diabetes, migraines, and osteoporosis.
Furthermore, CNAM provided inaugural funding for three high-cost specialized drugs targeting rare and severe conditions. These treatments specifically address the needs of patients suffering from hemophilia and multiple sclerosis.
Surge in surgical and orthopedic funding
CNAM reports that approximately 14,000 patients underwent cataract surgeries in 2025. The budget for these procedures reached 159 million MDL (approx. €8.1 million), marking a 7 million MDL increase compared to 2024.
Investment in musculoskeletal health also saw significant growth. Roughly 7,000 citizens received orthopedic prostheses, supported by a 501 million MDL (approx. €25.5 million) allocation, which represents a 49 million MDL rise over the previous year.
High-tech medical services and oncology
In 2025, the healthcare system delivered over 670,000 high-performance medical services. Funding for these services surpassed 408 million MDL, an increase of 71 million MDL from the prior year.
The "Oncology Patient" program remained a priority, facilitating over 13,000 appointments through the national reporting system. Computed Tomography (CT) scans accounted for nearly half of these requests, highlighting the continued demand for advanced diagnostics.
Focus on prevention and early detection
Authorities allocated 51 million MDL toward the prophylaxis fund, covering essential vaccines for rabies, influenza, and hepatitis.
Preventive screening programs reached thousands of citizens: 10,000 women underwent breast screenings, 7,000 individuals participated in colorectal screenings, and 10,000 people received lung screenings. Additionally, mobile dental teams provided specialized care to 11,000 children in rural communities.
Translation by Iurie Tataru
